Tablets and capsule shown are not actual size.
Depakote
125 mg
Depakote
250 mg
Depakote
500 mg
Depakote Delayed-Release Tablets are “delayed-release,” which means they have a special coating that prevents the drug from dissolving too early in the digestive tract. Available in three strengths, Depakote Delayed-Release Tablets must be taken twice a day, as prescribed by your doctor. Talk with your doctor about the most appropriate treatment choice for you.
Depakote ER
250 mg
Depakote ER
500 mg
The “ER” in Depakote ER stands for Extended Release. Available in two strengths, Depakote ER contains the same active ingredient as Depakote Delayed-Release Tablets but it is designed to slowly deliver the medication over a 24-hour period. This means that Depakote ER only has to be taken once a day. If you have been prescribed Depakote Delayed-Release Tablets, ask your doctor if Depakote ER is right for you.
Depakote Delayed-Release Tablets and Depakote ER should be swallowed whole and should not be crushed or chewed. Depakote tablets and capsules have a special coating to prevent the entire tablet from breaking down at the same time. This makes the tablet dissolve slowly, controlling the amount of medicine released into your system. Sometimes the shell does not completely dissolve and passes through your intestines with your stool. This is called a “ghost tablet,” and may contain a trace, if any, amount of medicine. If you have a shortened intestine (for example, from a colostomy or ileostomy) or an intestinal disorder and diarrhea, you may not have received all your medicine from the tablet. Notify your doctor if you notice a ghost tablet in your stool.
Depakote Sprinkle Capsules
125 mg
Available in 125 mg strength only, Depakote Sprinkle Capsules work in the same way as Depakote Delayed-Release tablets, although they are in a capsule form instead of a tablet. Some patients (for example, those who have difficulty swallowing) may find it easier to take Depakote Sprinkle Capsules because the capsules can be swallowed whole or opened and the contents sprinkled on soft food. Talk with your doctor about the most appropriate treatment choice for you.
Depakote Sprinkle Capsules are only approved for the treatment of epilepsy.
Available to patients with commercial prescription insurance coverage for Depakote who meet eligibility criteria. Copay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the Depakote Savings Card and patient must call OPUS Health at 800.364.4767 to stop participation. Patients residing in or receiving treatment in certain states may not be eligible. Patients may not seek reimbursement for value received from the Depakote Savings Card from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. Please see full Terms and Conditions.
Pharmacist Instructions
DEPAKOTE comes in different dosage forms. DEPAKOTE® (divalproex sodium) delayed-release tablets, for oral use, and DEPAKOTE® ER (divalproex sodium) extended-release tablets, for oral use, are prescription medications used:
DEPAKOTE® Sprinkle Capsules (divalproex sodium delayed release capsules), for oral use, is a prescription medicine used alone or with other medicines to treat:
The most important information about DEPAKOTE is:
Do not stop taking DEPAKOTE without first talking to your healthcare provider. Stopping DEPAKOTE suddenly can cause serious problems.
DEPAKOTE can cause serious side effects, including:
Do not take DEPAKOTE if you:
Before taking DEPAKOTE, tell your healthcare provider if you:
Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins, herbal supplements.
Taking DEPAKOTE with certain other medicines, even for a short period of time, can cause side effects or affect how well they work. Do not start or stop other medicines without talking to your healthcare provider.
DEPAKOTE can cause other serious side effects, including:
Common side effects of DEPAKOTE include:
Please see the full Prescribing Information, including Medication Guide, for additional information about DEPAKOTE. Talk to your healthcare provider if you have questions.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit Abbvie.com/myAbbVieAssist to learn more.
If you have any questions about AbbVie's Depakote.com website that have not been answered, click here. This website and the information contained herein is intended for use by US residents only, is provided for informational purposes only, and is not intended to replace a discussion with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider and consider the unique characteristics of each patient.
DEPAKOTE comes in different dosage forms. DEPAKOTE® (divalproex sodium) delayed-release tablets, for oral use, and DEPAKOTE® ER (divalproex sodium) extended-release tablets, for oral use, are prescription medications used:
The most important information about DEPAKOTE is:
Do not stop taking DEPAKOTE without first talking to your healthcare provider. Stopping DEPAKOTE suddenly can cause serious problems.
DEPAKOTE can cause serious side effects, including:
You are leaving the AbbVie website and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility.
Conversely, the presence of this link does not imply the linked site’s endorsement of Depakote.com or AbbVie.
Do you wish to leave this site?
You are about to enter a site that is for U.S. Healthcare Professionals only. By selecting "Yes" below, you certify that you are a Healthcare Professional and that you wish to proceed to the Healthcare Professionals Only section of this site. Products or treatments described on this site are available in the U.S. but may not be available in all other countries.
I am a licensed Healthcare Professional and wish to proceed to the Healthcare Professionals Only section of this site.
You are leaving the AbbVie website and connecting to the Track It! application on iTunes. This application is not a substitute for seizure safety. Please talk to your doctor for more information on seizure first aid. The Track It! application is not owned by or under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience, and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility.
Conversely, the presence of this link does not imply the linked site’s endorsement of Depakote.com or AbbVie.
Do you wish to leave this site?
The DEPAKOTE Savings Card is not available to individuals who are paying cash for their prescription or who are receiving prescription reimbursement under a state or federally funded insurance program.
This rebate form is not available to individuals who are paying cash for their prescription or who are receiving prescription reimbursement under a state or federally funded insurance program.